secwatch.observer — SEC 8-K summary
======================================

Issuer:     Liquidia Corp (LQDA)
CIK:        0001819576
Form:       8-K
Filed at:   2024-10-07T23:59:59+00:00
Accession:  0001104659-24-106685
Event type: litigation
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Supreme Court denies United Therapeutics' certiorari; Liquidia's '793 patent invalid final
--------------------------------------------------------------------------------

- Supreme Court rejected UTHR's cert petition, finalizing PTAB and Federal Circuit rulings that all claims of U.S. Patent No. 10,716,793 are invalid.
- No valid claims of the three patents originally asserted by UTHR found infringed; all decisions final and not subject to further appeal.
- FDA granted tentative approval of YUTREPIA for PAH and PH-ILD on Aug 16, 2024; final approval may occur after May 23, 2025.
- U.S. District Court denied UTHR's preliminary injunction on '327 patent; trial scheduled for June 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924106685/0001104659-24-106685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1819576/000110465924106685/tm2425742d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-106685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer